The Valley Desk

NCT03579966 · Interventional trial

Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Overall registry status Terminated

Phase 3

Conditions AChR Myasthenia Gravis, Myasthenia Gravis, MuSK

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov